Progressis emulsion for injection for pigs (sows and gilts).
Emulsion for injection. Each 2-ml dose of vaccine contains: Inactivated Porcine Reproductive and Respiratory Syndrome (PRRS) virus, P120 strain > 2.5 log10 IF units*, o/w oily excipient**, q.s. 2 ml.
* IF units: ImmunoFluorescence antibody titre obtained after 2 injections in pigs under specific laboratory conditions.
**containing hydrogenated polyisobutene as adjuvant.
Pigs (sows and gilts): Reduction of the reproductive disorders caused by Porcine Reproductive and Respiratory Syndrome Virus (European strain) in a contaminated environment: vaccination of sows and gilts reduces the number of early farrowings and the number of still-births.
Dosage and administration
One dose of 2 ml is administered by deep intramuscular route, in the neck muscles behind the ear, according to the following vaccination scheme:
Gilts: 2 injections 3-4 weeks apart, at least 3 weeks before mating.
Sows: 2 injections 3-4 weeks apart (vaccination of all the sows of the herd within a short period is recommended).
One injection at day 60-70 of each gestation, starting with the first pregnancy following primary vaccination.
Contra-indications, warnings, etc
For animal treatment only. There are no known contraindications. Apply usual aseptic procedures. Vaccinate only healthy animals. Apply the usual procedures for the handling of animals.
Vaccination may induce a transient oedema (at most 3 cm) lasting generally less than one week, and small local reactions (granulomas), without any effect on the health and reproductive performance of the animal. Larger reactions (up to 7 cm diameter) have been observed occasionally after frequent repeated revaccination. Vaccination may rarely cause hypersensitivity reactions. In such cases, an appropriate symptomatic treatment should be carried out.
Can be used during pregnancy and lactation.
Data are available which demonstrate that this vaccine can be administered on the same day at a separate site, with inactivated vaccines against parvovirosis, influenza and Aujeszky's disease as no adverse effect on the serological response has been observed.
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the products mentioned above. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
To the user
This product contains mineral oil. Accidental injection/self injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given.
If you are accidentally injected with this product, seek prompt medical advice even if only a very small amount is injected and take the package insert with you. If pain persists for more than 12 hours after medical examination, seek medical advice again.
To the physician
This product contains mineral oil. Even if small amounts have been injected, accidental injection with this product can cause intense swelling, which may, for example, result in ischaemic necrosis and even the loss of a digit. Expert, PROMPT, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where there is involvement of finger pulp or tendon.
Keep out of the reach and sight of children.
Use immediately after first opening the vial.
Do not mix with any other veterinary medicinal product.
Store in a refrigerator (2°C – 8°C). Do not freeze.
Protect from light.
Any unused product or waste material should be disposed of in accordance with national requirements.
Box of 1 bottle of 5 doses.
Box of 1 bottle of 25 doses.